Cargando…
A novel spontaneous hepatocellular carcinoma mouse model for studying T-cell exhaustion in the tumor microenvironment
Immunotherapy has ushered in a new era of cancer therapy, and this is also applicable to therapy of hepatocellular carcinoma (HCC). In this context, effective development of therapeutic strategies requires an HCC mouse model with known tumor-associated antigens (TAAs) and an HCC growth reporter. We...
Autores principales: | Liu, Yu-Tzu, Tseng, Tai-Chung, Soong, Ruey-Shyang, Peng, Chun-Yi, Cheng, Yu-Hsing, Huang, Shiu-Feng, Chuang, Tsung-Hsien, Kao, Jia-Horng, Huang, Li-Rung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286542/ https://www.ncbi.nlm.nih.gov/pubmed/30526672 http://dx.doi.org/10.1186/s40425-018-0462-3 |
Ejemplares similares
-
Should we change the treatment plan in early hepatocellular carcinoma with chronic kidney disease?
por: Chao, Wu-Po, et al.
Publicado: (2023) -
Adjuvant Effect of Toll-Like Receptor 9 Activation on Cancer Immunotherapy Using Checkpoint Blockade
por: Chuang, Yu-Chen, et al.
Publicado: (2020) -
Exhaust the exhausters: Targeting regulatory T cells in the tumor microenvironment
por: McRitchie, Bayley R., et al.
Publicado: (2022) -
T-cell exhaustion in the tumor microenvironment
por: Jiang, Y, et al.
Publicado: (2015) -
Bis-benzylidine Piperidone RA190 treatment of hepatocellular carcinoma via binding RPN13 and inhibiting NF-κB signaling
por: Soong, Ruey-Shyang, et al.
Publicado: (2020)